VENCF (Vencanna Ventures) EBIT per Share: $-0.01 (TTM As of Jan. 2026)


What is Vencanna Ventures EBIT per Share?

Vencanna Ventures VENCF +80.00% EBIT per Share is $-0.01 as of Jan. 2026. The stock has 4 warning signs investors should review. Among 808 Drug Manufacturers companies, Vencanna Ventures ranks worse than 93.07% on this metric.

Vencanna Ventures's EBIT per Share for the three months ended in Jan. 2026 was $-0.00. Its EBIT per Share for the trailing twelve months (TTM) ended in Jan. 2026 was $-0.01.

During the past 3 years, the average EBIT per Share Growth Rate was -40.90% per year. During the past 5 years, the average EBIT per Share Growth Rate was -17.70% per year. During the past 10 years, the average EBIT per Share Growth Rate was -25.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Vencanna Ventures's EBIT per Share or its related term are showing as below:

VENCF' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -166.8   Med: 33.1   Max: 69
Current: -40.9

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Vencanna Ventures was 69.00% per year. The lowest was -166.80% per year. And the median was 33.10% per year.

VENCF's 3-Year EBIT Growth Rate is ranked worse than
93.07% of 808 companies
in the Drug Manufacturers industry
Industry Median: 7.65 vs VENCF: -40.90

Vencanna Ventures's EBIT for the three months ended in Jan. 2026 was $-0.26 Mil.

Vencanna Ventures  (OTCPK:VENCF) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Vencanna Ventures EBIT per Share Related Terms

Vencanna Ventures EBIT per Share Historical Data

* Premium members only.

The historical data trend for Vencanna Ventures's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vencanna Ventures EBIT per Share Chart

Vencanna Ventures Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.00 -0.00 -0.00 -0.02

Vencanna Ventures Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 -0.00 -0.00 -0.00 -0.00

Vencanna Ventures EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Vencanna Ventures's EBIT per Share for the fiscal year that ended in Apr. 2025 is calculated as

EBIT per Share(A: Apr. 2025 )
=EBIT/Shares Outstanding (Diluted Average)
=-4.01/222.645
=-0.02

Vencanna Ventures's EBIT per Share for the quarter that ended in Jan. 2026 is calculated as

EBIT per Share(Q: Jan. 2026 )
=EBIT/Shares Outstanding (Diluted Average)
=-0.255/222.645
=-0.00

EBIT per Share for the trailing twelve months (TTM) ended in Jan. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT per Share →
What does a EBIT per Share of $-0.01 mean?
Vencanna Ventures (VENCF) has a EBIT per Share of $-0.01 as of Jan. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Vencanna Ventures and its competitors. According to the industry distribution chart, Vencanna Ventures ranks #752 out of 808 companies in the Drug Manufacturers industry, placing it in the top 93.1%.
Is Vencanna Ventures' EBIT per Share too high?
Vencanna Ventures' current EBIT per Share is $-0.01. Based on the distribution chart, Vencanna Ventures ranks #752 out of 808 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Vencanna Ventures' EBIT per Share compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vencanna Ventures ranks #752 out of 808 companies for EBIT per Share. This places Vencanna Ventures in the lower half of its industry. The industry median EBIT per Share is 7.65. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.65, based on 808 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Vencanna Ventures and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vencanna Ventures's current EBIT per Share is $-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vencanna Ventures stock overvalued right now?
Vencanna Ventures (VENCF) has a current EBIT per Share of $-0.01. The current EBIT per Share is $-0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Vencanna Ventures (VENCF), the current EBIT per Share is $-0.01 as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vencanna Ventures Business Description

Other Exchanges VENI:Canada
Address 622 5th Avenue SW, Suite 200, Calgary, AB, CAN, T2P 0M6
Vencanna Ventures Inc aims to provide investors with a diversified, high-growth, cannabis investment plan through strategic investments and acquisitions focused throughout the value chain (cultivation, processing, and distribution), including ancillary businesses. The company generates the majority of its revenue from the United States.